Kynam Capital Management, LP
Source: SEC Form 13F · as of Mar 2026Kynam Capital Management, LP holds 22 biotech & pharma companies tracked by BioSniper, totaling $790.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$790.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Vaxcyte, Inc. (PCVX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PCVXVaxcyte, Inc. | 2,922,335 | $169.8M |
| COGTCogent Biosciences, Inc. | 4,037,331 | $155.4M |
| TVTXTravere Therapeutics, Inc. | 2,423,918 | $72.0M |
| BCRXBIOCRYST PHARMACEUTICALS INC | 5,680,795 | $54.1M |
| VRDNViridian Therapeutics, Inc.\DE | 2,341,652 | $45.8M |
| KALVKalVista Pharmaceuticals, Inc. | 1,820,954 | $36.7M |
| APLSApellis Pharmaceuticals, Inc. | 825,000 | $33.2M |
| LEGNLegend Biotech Corp | 1,576,295 | $28.5M |
| MBXMBX Biosciences, Inc. | 934,799 | $27.9M |
| IMCRImmunocore Holdings plc | 884,937 | $26.7M |
| RVMDREVOLUTION MEDICINES, INC. | 207,500 | $20.2M |
| SLNOSOLENO THERAPEUTICS INC | 560,000 | $18.7M |
| NRIXNurix Therapeutics, Inc. | 1,194,757 | $18.5M |
| PHVSPharvaris N.V. | 640,395 | $18.1M |
| EVMNEvommune, Inc. | 625,496 | $14.4M |
| RLAYRelay Therapeutics, Inc. | 1,424,259 | $14.2M |
| GERNGERON CORP | 6,836,318 | $10.2M |
| DSGNDesign Therapeutics, Inc. | 784,606 | $8.3M |
| WVEWave Life Sciences Ltd. | 965,193 | $7.0M |
| BHVNBiohaven Ltd. | 702,884 | $5.9M |
| ALECAlector, Inc. | 2,000,000 | $4.3M |
| CADLCandel Therapeutics, Inc. | 200,000 | $980K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.